Skip to content

Effectiveness of VestAid App

Vestibular Rehabilitation Aid (VestAid)

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06683417
Enrollment
80
Registered
2024-11-12
Start date
2025-01-15
Completion date
2025-12-30
Last updated
2024-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balance Deficits, Dizziness, MTBI - Mild Traumatic Brain Injury, Vestibular Disease, Vestibular Disorders

Keywords

mTBI, vestibular rehabilitation, vestibular disorder, technology, application, dizziness, balance disorder, image processing, eye gaze compliance, VOR

Brief summary

This multi-center randomized trial (MCRT) will investigate the effectiveness of the VestAid application to provide equivalent or faster recovery from dizziness compared to standard-of-care delivery of vestibular rehabilitation exercises.

Interventions

DEVICEVestibular Rehabilitation Aid

The tablet-based VestAid system was developed to repair, restore and maintain vestibular-ocular function that is impaired in patients post-mTBI. Each participant's treating physical therapist will develop their own personalized exercise prescription. The physical therapist will be asked to recommend that the patients complete a home exercise program at least 2-3 times per day for 6 weeks. The exercise prescription will be placed on the VestAid by the physical therapist for the patient to follow. The patient is not able to modify the exercise, only the physical therapist can modify the exercises. Exercises will be modified based on patient's response and symptom reports. The physical therapist and study coordinator will receive an alert on the VestAid online dashboard if the patient's symptoms are greater than or equal to 8/10.

OTHERStandard of care vestibular rehabilitation

Vestibular rehabilitation to include gaze stabilization exercises, optokinetic training, smooth pursuits and saccades

Sponsors

University of Pittsburgh
CollaboratorOTHER
BlueHalo
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Inclusion: * Snellen visual acuity (corrected) greater than 20/40 * No more than 25dB hearing loss at 500,1000, 2000, and 4000 Hz * Ability to detect 4.31 using Semmes-Weinstein monofilament at the lower extremity * At least 40 degrees of neck yaw motion with only mild to moderate pain (6 or under on 0-10 numeric pain scale) * Internet access at home * No significant residual from past musculoskeletal or neuromuscular conditions * Ability ambulates unassisted * Diagnosed with a concussion or inner ear problem the last 30 days * Between 18-60 years of age * Can read and understand English * Has complaints of dizziness

Exclusion criteria

* Greater then 30 days since diagnosis of concussion/mTBI or inner ear problem * No access to internet at home * Younger than 18 years of age or older than 60 years of age * Cannot read or understand English * No complaints of dizziness and/or balance deficits * Have significant neuropathy * Cannot see tablet clearly at 1 meter * Neck pain >5 on a 10-point pain scale.

Design outcomes

Primary

MeasureTime frameDescription
Dizziness Handicap Inventory (DHI)From enrollment weekly for 6 weeks.A self report measure of dizziness (questionnaire)

Secondary

MeasureTime frameDescription
Secondary EndpointFrom enrollment weekly for 6 weeksSubjective symptom reporting of dizziness, headache, nausea, and fogginess

Countries

United States

Contacts

Primary ContactSusan L Whitney, DPT, PhD, NCS, ATC, FAPTA
whitney@pitt.edu412-383-6642
Backup ContactChelsea J Manetta, PT, DPT, NCS
cjm294@pitt.edu4126487964

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026